NZ's RNA tech opportunity

NZ's RNA tech opportunity
The government committed $40.7 million for RNA technology in the budget. (Image: Getty)
Peter Griffin
Two years ago, New York yoga teacher Melissa Honkanen became the first person in the world to be vaccinated with the Pfizer-BioNTech coronavirus vaccine.She was part of a clinical trial being run at New York University’s Langone Medical Centre as the world scrambled to deal with the spread of covid-19.“My husband asked, do you want to join this? I thought: 'yeah, this is a no-brainer for me. We’ve got to do something; this is not a sustainable life that we have',” she said last month.The majority of adult New Zea...

More Opinion

Token-ology: the next thing
Opinion

David Chaplin: Token-ology: the next thing

Despite promising developments, fund tokenisation remains in an experimental phase.

David Chaplin 11 Dec 2024
Covid helped polarise us
Opinion

Sir Peter Gluckman: Covid helped polarise us

The pandemic's consequences continue to reverberate. 

Rangatira eyes international stocks
Opinion

Paul McBeth: Rangatira eyes international stocks

The investment firm is finding things tough going for local holdings.

Paul McBeth 10 Dec 2024
Nabers, everybody needs good Nabers
Property Opinion

Maria Slade: Nabers, everybody needs good Nabers

New Zealand is 15 years behind Australia in encouraging green building.

Maria Slade 09 Dec 2024